These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1144070

  • 1. [Immunological factors in the origin and development of neoplasms. I].
    Steffin J.
    Nowotwory; 1975; 25(2):123-33. PubMed ID: 1144070
    [No Abstract] [Full Text] [Related]

  • 2. How efficient is immunological surveillance against cancer and why does it fail?
    Laroye GJ.
    Lancet; 1974 Jun 01; 1(7866):1097-1100. PubMed ID: 4135256
    [No Abstract] [Full Text] [Related]

  • 3. [Tumor antigens and immune reactions against tumors].
    Trepel F.
    Med Klin; 1971 Feb 12; 66(7):215-22. PubMed ID: 4928396
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IMMUNOLOGICAL TOLERANCE AND THE CANCER PROBLEM.
    HASEK M, SVOBODA J, KOLDOVSKY P.
    Philipp J Cancer; 1963 Feb 12; 5():535-9. PubMed ID: 14232627
    [No Abstract] [Full Text] [Related]

  • 7. [Specific neoplastic antigens].
    Dux K.
    Pol Arch Med Wewn; 1970 Feb 12; 45(6):745-53. PubMed ID: 5505267
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Current and prospective problems in tumor immunology].
    Pitzurra M.
    Boll Ist Sieroter Milan; 1971 Feb 12; 50(3):209-20. PubMed ID: 4947785
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor immunology.
    McKhann CF, Yarlott MA.
    CA Cancer J Clin; 1975 Feb 12; 25(4):187-97. PubMed ID: 805638
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunological approaches to the treatment of solid tumors].
    May-Levin F.
    Boll Ist Sieroter Milan; 1971 Feb 12; 50(3):221-30. PubMed ID: 4111987
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.
    Schwartz RS, Beldotti L.
    Science; 1965 Sep 24; 149(3691):1511-4. PubMed ID: 5828031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.